Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease

Autor: Peter C. Taylor, Ayman Askari, Ernest Choy, Michael R. Ehrenstein, Sara Else, Muhammad K. Nisar

Publikováno v: BMC Medicine, Vol 21, Iss 1, Pp 1-10 (2023)

Abstract Background Rheumatoid arthritis (RA) is a chronic inflammatory disease that is associated with joint pain and stiffness. Biologics represent some of the most effective treatments for RA, but previous guidance from the National Institute for

Externí odkaz: https://doaj.org/article/7b0471b44dda43c790c34ef8738fd283

P060 A survey of COVID-19 infections in rheumatology patients in Shropshire, UK

Autor: Ali El Rashid, Raghvendra Prasad Patil, Lisa Burgress, Patrick Ball, Hannah Morrissey, Ayman Askari

Publikováno v: Rheumatology. 62

Background/Aims To assess the incidence and vulnerability of rheumatology patients to COVID-19 infection in early stages of pandemic. Methods Self completed questionnaire was posted to patients. Results Patients diagnosed with rheumatic diseases were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9aed12e7b4c85069de29c62123de1eae
https://doi.org/10.1093/rheumatology/kead104.101

Baricitinib in Rheumatoid Arthritis – Real World Cross-Sectional Study

Autor: Hana Morrissey, Patrick Ball, Amol Sagdeo, Ayman Askari

Publikováno v: The Open Rheumatology Journal. 14:28-33

Introduction: Rheumatoid Arthritis (RA) is the most common cause of inflammatory polyarthritis. In RA, increased circulating levels of pro-inflammatory cytokines contribute to the overall symptomatology of fatigue, pain, and joint stiffness. Bariciti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0357d4f5ace01f828c8ea779c00d23a4
https://doi.org/10.2174/1874312902014010028

Steroid-Sparing Agents in Giant Cell Arteritis

Autor: Patrick Ball, Ayman Askari, Josh Dixey, Amol Sagdeo, Hana Morrissey

Publikováno v: The Open Rheumatology Journal. 13:61-71

Background: Giant cell arteritis is the commonest form of medium-to-large vessel vasculitis, requiring long-term corticosteroid therapy. The short- and long-term side effects of corticosteroids are many, including weight gain, psychological effects,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cc39ce8fdfc8f1144f2822b37adc6823
https://doi.org/10.2174/1874312901913010061

Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis

Autor: Neil McHugh, Amelia Jobling, SE Lane, Gavin Shaddick, Philip S. Helliwell, William Tillett, Annie Cooper, J. Packham, Lesley Kay, Paul Creamer, Ragai Shaban, Eleanor Korendowych, Ayman Askari, Jana James, Gavin Clunie, Matthew L. Thomas, Lyn Williamson

Publikováno v: Tillett, W, Shaddick, G, Jobling, A, Askari, A, Cooper, A, Creamer, P, Clunie, G, Helliwell, P S, James, J, Kay, L, Korendowych, E, Lane, S, Packham, J, Shaban, R, Thomas, M L, Williamson, L & McHugh, N 2017, ' Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis ', Rheumatology (United Kingdom), vol. 56, no. 4, pp. 603-612 . https://doi.org/10.1093/rheumatology/kew433
Tillett, W, Shaddick, G, Jobling, A, Askari, A, Cooper, A, Creamer, P, Clunie, G, Helliwell, P S, James, J, Kay, L, Korendowych, E, Lane, S, Packham, J, Shaban, R, Thomas, M L, Williamson, L & McHugh, N 2017, ' Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis ', Rheumatology, vol. 56, no. 4, pp. 603-612 . https://doi.org/10.1093/rheumatology/kew433

OBJECTIVE: To determine the effect of medical treatment on work disability in patients with active PsA in a real-world setting.METHODS: Four hundred patients with active PsA commencing or switching to anti-TNF or conventional synthetic DMARD (csDMARD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e367b5cb7c5b39e8c187da5d87a4b2e7
https://doi.org/10.1093/rheumatology/kew433